Mosharraf Hossen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mosharraf Hossen has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Kazi Abdus Sobur
Department of Microbiology and Hygiene Bangladesh Agricultural University -2202 Mymensingh Bangladesh
5 shared publications - Zaminur Rahman
Gono University
4 shared publications - Palash Bose
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh
3 shared publications - Sakib Mowdood3 shared publications
- Ashiquen Nobi
Bangladesh Agricultural University, Bangladesh
2 shared publications - Partha Pratim Ghosh
School of Engineering Technology and Applied Science (Biotechnology), Cenetennial College, 755 Morningside Ave, Scarborough, ON M1C 4Z4, Canada
2 shared publications
Latest Publications
- Open Access
- 26 July 2026
- Published by Genesis Publishing Consortium Limited
- Vol. 2 (1) , 1-4
Plant biotechnology as a catalyst for sustainable agricultural transformation
Agricultural systems are increasingly challenged by climate change, resource scarcity, environmental degradation, and the need to ensure food security for a growing global population. Addressing these multifaceted challenges requires innovative, science-driven approaches that enhance productivity while promoting ecological sustainability. This editorial examines the evolving role of plant biotechnology as a key driver of modern agricultural advancement, highlighting recent developments in genomics, multi-omics technologies, molecular breeding, genome editing, plant tissue culture, and digital agriculture. It discusses how these technologies contribute to the development of resilient crop varieties with improved tolerance to biotic and abiotic stresses, enhanced nutrient-use efficiency, and superior agronomic performance. The editorial further emphasizes the integration of artificial intelligence, high-throughput phenotyping, bioinformatics, and systems biology into precision crop improvement, enabling more efficient translation of molecular discoveries into field applications. The importance of interdisciplinary collaboration, responsible innovation, biosafety, and science-based regulatory frameworks is also considered in supporting the sustainable deployment of emerging biotechnologies. Looking ahead, the convergence of advanced molecular tools with computational and ecological sciences is expected to accelerate the development of resilient agricultural systems capable of addressing future environmental and food production challenges. Continued investment in research, technological innovation, and international collaboration will be essential to maximize the societal and environmental benefits of next-generation crop improvement strategies.
- 26 July 2026
- Published by Genesis Publishing Consortium Limited
- Vol. 2 (1) , 1-4
Open AccessPlant biotechnology as a catalyst for sustainable agricultural transformation
Agricultural systems are increasingly challenged by climate change, resource scarcity, environmental degradation, and the need to ensure food security for a growing global population. Addressing these multifaceted challenges requires innovative, science-driven approaches that enhance productivity while promoting ecological sustainability. This editorial examines the evolving role of plant biotechnology as a key driver of modern agricultural advancement, highlighting recent developments in genomics, multi-omics technologies, molecular breeding, genome editing, plant tissue culture, and digital agriculture. It discusses how these technologies contribute to the development of resilient crop varieties with improved tolerance to biotic and abiotic stresses, enhanced nutrient-use efficiency, and superior agronomic performance. The editorial further emphasizes the integration of artificial intelligence, high-throughput phenotyping, bioinformatics, and systems biology into precision crop improvement, enabling more efficient translation of molecular discoveries into field applications. The importance of interdisciplinary collaboration, responsible innovation, biosafety, and science-based regulatory frameworks is also considered in supporting the sustainable deployment of emerging biotechnologies. Looking ahead, the convergence of advanced molecular tools with computational and ecological sciences is expected to accelerate the development of resilient agricultural systems capable of addressing future environmental and food production challenges. Continued investment in research, technological innovation, and international collaboration will be essential to maximize the societal and environmental benefits of next-generation crop improvement strategies.
- 5 May 2026
- Published by Genesis Publishing Consortium Limited
- Vol. 2 (1) , 1-4
Combating antimicrobial resistance through innovative pharmacological approaches
Antimicrobial resistance (AMR) represents a critical and escalating threat to global health, compromising the effectiveness of existing therapies and increasing morbidity, mortality, and healthcare costs. This editorial examines innovative pharmacological strategies to address AMR, emphasizing the need for a multifaceted and sustainable approach. Advances in drug discovery, including novel antimicrobial agents and anti-virulence therapies, are reshaping the treatment landscape. Drug repurposing and combination therapies offer immediate, cost-effective solutions, while cutting-edge drug delivery systems enhance therapeutic precision and reduce resistance selection. The integration of pharmacokinetic and pharmacodynamic principles, alongside personalized medicine, supports optimized dosing and improved clinical outcomes. Emerging approaches such as bacteriophage therapy, immunomodulation, and microbiome-based interventions further expand the arsenal against resistant pathogens. However, scientific innovation must be complemented by robust pharmacovigilance, antimicrobial stewardship, and supportive regulatory and economic frameworks. Global collaboration and equitable access to therapies remain essential to mitigate the spread of resistance. Collectively, these strategies underscore the pivotal role of pharmacology in combating AMR and ensuring the long-term efficacy of antimicrobial interventions.
- 5 May 2026
- Published by Genesis Publishing Consortium Limited
- Vol. 2 (1) , 1-4
Combating antimicrobial resistance through innovative pharmacological approaches
Antimicrobial resistance (AMR) represents a critical and escalating threat to global health, compromising the effectiveness of existing therapies and increasing morbidity, mortality, and healthcare costs. This editorial examines innovative pharmacological strategies to address AMR, emphasizing the need for a multifaceted and sustainable approach. Advances in drug discovery, including novel antimicrobial agents and anti-virulence therapies, are reshaping the treatment landscape. Drug repurposing and combination therapies offer immediate, cost-effective solutions, while cutting-edge drug delivery systems enhance therapeutic precision and reduce resistance selection. The integration of pharmacokinetic and pharmacodynamic principles, alongside personalized medicine, supports optimized dosing and improved clinical outcomes. Emerging approaches such as bacteriophage therapy, immunomodulation, and microbiome-based interventions further expand the arsenal against resistant pathogens. However, scientific innovation must be complemented by robust pharmacovigilance, antimicrobial stewardship, and supportive regulatory and economic frameworks. Global collaboration and equitable access to therapies remain essential to mitigate the spread of resistance. Collectively, these strategies underscore the pivotal role of pharmacology in combating AMR and ensuring the long-term efficacy of antimicrobial interventions.
- Open Access
- 30 March 2026
- Published by Genesis Publishing Consortium Limited in Journal of Bioscience and Environment Research
- Vol. 3 (1) , 13-19
Prevalence, molecular detection, and antimicrobial resistance profiles of Staphylococcus aureus and Escherichia coli in raw milk from urban milk markets of southwestern Bangladesh
Raw milk is widely consumed in Bangladesh; however, poor hygienic conditions during milking, handling, and marketing may lead to contamination with pathogenic bacteria, posing potential risks to public health. This study aimed to isolate, identify, and molecularly detect Staphylococcus aureus and Escherichia coli from raw milk samples sold in Kushtia Sadar, Bangladesh. A total of 90 raw milk samples were aseptically collected from various local markets in Kushtia Sadar. The samples were examined for the isolation and identification of the target bacteria using cultural characteristics, Gram staining, biochemical tests, and molecular techniques. Molecular confirmation of S. aureus was performed by amplifying the nuc gene, while E. coli was detected using PCR targeting the 16S rRNA gene. Among the 90 samples, 35 (95% CI: 28.8%–49.0%; p = 0.031) were culture-positive for S. aureus, and 20 (95% CI: 13.6%–30.8%; p = 0.001) were culture-positive for E. coli. Molecular analysis revealed that 16 of the S. aureus isolates (45.7%, 95% CI: 29.2%–62.2%; p = 0.61) were positive for the nuc gene, while 9 of the E. coli isolates (45.0%, 95% CI: 23.2%–66.8%; p = 0.65) carried the 16S rRNA gene. The antibiogram profiles showed that most nuc gene-positive S. aureus isolates were highly resistant to vancomycin (50%), penicillin (100%), cefoxitin (100%), and oxacillin (100%), but exhibited high sensitivity to levofloxacin, norfloxacin, and doxycycline (100%). In contrast, the 16S rRNA gene–positive E. coli isolates demonstrated high resistance to ampicillin (100%) and cotrimoxazole (44.44%). The highest sensitivity was observed against gentamicin and nitrofurantoin (88.88%), while the lowest sensitivity was recorded for ampicillin (0%) and cefotaxime (11.11%). The findings of this study indicate that raw milk sold in Kushtia Sadar may serve as a potential reservoir for pathogenic and antibiotic-resistant bacteria, posing significant public health risks if consumed without proper processing.
- 30 March 2026
- Published by Genesis Publishing Consortium Limited in Journal of Bioscience and Environment Research
- Vol. 3 (1) , 13-19
Open AccessPrevalence, molecular detection, and antimicrobial resistance profiles of Staphylococcus aureus and Escherichia coli in raw milk from urban milk markets of southwestern Bangladesh
Raw milk is widely consumed in Bangladesh; however, poor hygienic conditions during milking, handling, and marketing may lead to contamination with pathogenic bacteria, posing potential risks to public health. This study aimed to isolate, identify, and molecularly detect Staphylococcus aureus and Escherichia coli from raw milk samples sold in Kushtia Sadar, Bangladesh. A total of 90 raw milk samples were aseptically collected from various local markets in Kushtia Sadar. The samples were examined for the isolation and identification of the target bacteria using cultural characteristics, Gram staining, biochemical tests, and molecular techniques. Molecular confirmation of S. aureus was performed by amplifying the nuc gene, while E. coli was detected using PCR targeting the 16S rRNA gene. Among the 90 samples, 35 (95% CI: 28.8%–49.0%; p = 0.031) were culture-positive for S. aureus, and 20 (95% CI: 13.6%–30.8%; p = 0.001) were culture-positive for E. coli. Molecular analysis revealed that 16 of the S. aureus isolates (45.7%, 95% CI: 29.2%–62.2%; p = 0.61) were positive for the nuc gene, while 9 of the E. coli isolates (45.0%, 95% CI: 23.2%–66.8%; p = 0.65) carried the 16S rRNA gene. The antibiogram profiles showed that most nuc gene-positive S. aureus isolates were highly resistant to vancomycin (50%), penicillin (100%), cefoxitin (100%), and oxacillin (100%), but exhibited high sensitivity to levofloxacin, norfloxacin, and doxycycline (100%). In contrast, the 16S rRNA gene–positive E. coli isolates demonstrated high resistance to ampicillin (100%) and cotrimoxazole (44.44%). The highest sensitivity was observed against gentamicin and nitrofurantoin (88.88%), while the lowest sensitivity was recorded for ampicillin (0%) and cefotaxime (11.11%). The findings of this study indicate that raw milk sold in Kushtia Sadar may serve as a potential reservoir for pathogenic and antibiotic-resistant bacteria, posing significant public health risks if consumed without proper processing.
- Open Access
- 30 June 2025
- Published by Genesis Publishing Consortium Limited in Journal of Aquatic Research and Sustainability
- Vol. 2 (2) , 30-35
Hydroponic fodder: A sustainable solution for enhancing livestock nutrition and productivity
Livestock farming is a cornerstone of global food production; however, traditional fodder cultivation faces increasing challenges due to land scarcity, climate change, and rising feed costs. As a sustainable alternative, hydroponic fodder production has gained significant attention, providing nutrient-rich feed grown in a controlled, soil-free environment. This review explores the nutritional advantages of hydroponic fodder, highlighting its higher protein content, improved digestibility, and enhanced vitamin and mineral profile compared to conventional feed. We examine its impact on livestock performance, noting increased milk yield in dairy cattle, better weight gain in beef cattle, and improved reproductive efficiency in small ruminants. Additionally, we discuss the economic and environmental benefits, such as reduced water usage, minimal land requirements, and lower feed costs, making it an attractive option for farmers worldwide. While hydroponic fodder presents a promising solution for sustainable livestock farming, challenges remain, including scalability, initial investment costs, and the need for further research to optimize production systems. By addressing these hurdles, hydroponic technology has the potential to revolutionize animal agriculture, ensuring food security and environmental sustainability for future generations.
- 30 June 2025
- Published by Genesis Publishing Consortium Limited in Journal of Aquatic Research and Sustainability
- Vol. 2 (2) , 30-35
Open AccessHydroponic fodder: A sustainable solution for enhancing livestock nutrition and productivity
Livestock farming is a cornerstone of global food production; however, traditional fodder cultivation faces increasing challenges due to land scarcity, climate change, and rising feed costs. As a sustainable alternative, hydroponic fodder production has gained significant attention, providing nutrient-rich feed grown in a controlled, soil-free environment. This review explores the nutritional advantages of hydroponic fodder, highlighting its higher protein content, improved digestibility, and enhanced vitamin and mineral profile compared to conventional feed. We examine its impact on livestock performance, noting increased milk yield in dairy cattle, better weight gain in beef cattle, and improved reproductive efficiency in small ruminants. Additionally, we discuss the economic and environmental benefits, such as reduced water usage, minimal land requirements, and lower feed costs, making it an attractive option for farmers worldwide. While hydroponic fodder presents a promising solution for sustainable livestock farming, challenges remain, including scalability, initial investment costs, and the need for further research to optimize production systems. By addressing these hurdles, hydroponic technology has the potential to revolutionize animal agriculture, ensuring food security and environmental sustainability for future generations.
- Open Access
- 8 March 2025
- Published by Genesis Publishing Consortium Limited in Journal of Bioscience and Environment Research
- Vol. 2 (4) , 1-3
Advances in DNA replication research for precision medicine
DNA replication is a fundamental biological process ensuring genetic continuity and cellular function. Recent advances in molecular biology have deepened our understanding of the mechanisms governing DNA replication and their implications for human health. Disruptions in replication processes are linked to various diseases, particularly cancer, where replication stress and genetic instability drive tumorigenesis. Cutting-edge research, including high-resolution structural studies, single-molecule technologies, and genomic and proteomic approaches, has provided valuable insights into the molecular machinery involved in replication. These discoveries have paved the way for precision medicine applications, including targeted cancer therapies, gene editing advancements, and biomarker identification. The development of ATR and CHK1 inhibitors, as well as PARP inhibitors for BRCA-mutated cancers, exemplifies the clinical potential of DNA replication research. Despite significant progress, challenges remain in translating these findings into effective therapies due to the complexity of replication dynamics and the need for specificity in targeting replication proteins. Future research integrating multidisciplinary approaches, artificial intelligence, and computational modeling will enhance our ability to harness DNA replication knowledge for therapeutic innovation. This review highlights the critical role of DNA replication studies in advancing precision medicine and underscores the necessity of continued exploration to improve patient outcomes.
- 8 March 2025
- Published by Genesis Publishing Consortium Limited in Journal of Bioscience and Environment Research
- Vol. 2 (4) , 1-3
Open AccessAdvances in DNA replication research for precision medicine
DNA replication is a fundamental biological process ensuring genetic continuity and cellular function. Recent advances in molecular biology have deepened our understanding of the mechanisms governing DNA replication and their implications for human health. Disruptions in replication processes are linked to various diseases, particularly cancer, where replication stress and genetic instability drive tumorigenesis. Cutting-edge research, including high-resolution structural studies, single-molecule technologies, and genomic and proteomic approaches, has provided valuable insights into the molecular machinery involved in replication. These discoveries have paved the way for precision medicine applications, including targeted cancer therapies, gene editing advancements, and biomarker identification. The development of ATR and CHK1 inhibitors, as well as PARP inhibitors for BRCA-mutated cancers, exemplifies the clinical potential of DNA replication research. Despite significant progress, challenges remain in translating these findings into effective therapies due to the complexity of replication dynamics and the need for specificity in targeting replication proteins. Future research integrating multidisciplinary approaches, artificial intelligence, and computational modeling will enhance our ability to harness DNA replication knowledge for therapeutic innovation. This review highlights the critical role of DNA replication studies in advancing precision medicine and underscores the necessity of continued exploration to improve patient outcomes.
- Open Access
- 26 January 2025
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 01-03
The future of precision medicine: Integrating genetic engineering into pharmacological research
The integration of genetic engineering into pharmacological research is transforming the landscape of precision medicine, offering the potential to revolutionize healthcare. Precision medicine focuses on tailoring treatments to individuals based on genetic, environmental, and lifestyle factors, moving beyond the traditional “one-size-fits-all” approach. This editorial highlights the pivotal role of genetic engineering in advancing precision medicine, exploring its applications in drug discovery, pharmacogenomics, and innovative therapies such as gene and cell treatments. Tools like CRISPR-Cas9 and advancements in omics technologies have accelerated the development of personalized therapies and enhanced our understanding of disease mechanisms. Despite these breakthroughs, challenges persist. Technical hurdles like off-target effects, ethical concerns surrounding germline editing, and the high costs of these technologies must be addressed. Opportunities, however, abound—ranging from artificial intelligence-driven innovations to collaborative research initiatives, which promise to streamline the development of genetic engineering applications. This convergence of disciplines is not only reshaping drug development but also expanding the therapeutic arsenal to tackle complex diseases. With sustained investment, interdisciplinary collaboration, and an emphasis on equitable access, the promise of precision medicine—treatments tailored to each individual’s genetic blueprint—is rapidly becoming a reality.
- 26 January 2025
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 01-03
Open AccessThe future of precision medicine: Integrating genetic engineering into pharmacological research
The integration of genetic engineering into pharmacological research is transforming the landscape of precision medicine, offering the potential to revolutionize healthcare. Precision medicine focuses on tailoring treatments to individuals based on genetic, environmental, and lifestyle factors, moving beyond the traditional “one-size-fits-all” approach. This editorial highlights the pivotal role of genetic engineering in advancing precision medicine, exploring its applications in drug discovery, pharmacogenomics, and innovative therapies such as gene and cell treatments. Tools like CRISPR-Cas9 and advancements in omics technologies have accelerated the development of personalized therapies and enhanced our understanding of disease mechanisms. Despite these breakthroughs, challenges persist. Technical hurdles like off-target effects, ethical concerns surrounding germline editing, and the high costs of these technologies must be addressed. Opportunities, however, abound—ranging from artificial intelligence-driven innovations to collaborative research initiatives, which promise to streamline the development of genetic engineering applications. This convergence of disciplines is not only reshaping drug development but also expanding the therapeutic arsenal to tackle complex diseases. With sustained investment, interdisciplinary collaboration, and an emphasis on equitable access, the promise of precision medicine—treatments tailored to each individual’s genetic blueprint—is rapidly becoming a reality.
- Open Access
- 25 January 2025
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 01-04
Genetic engineering in agriculture: Bridging plant science and molecular biology for sustainable solutions
Genetic engineering in agriculture has emerged as a groundbreaking approach to tackling some of the most pressing challenges of the modern era, including food security, environmental sustainability, and malnutrition. By integrating plant science with molecular biology, this innovative technology enables the development of crops that are more resilient to environmental stressors, enriched with essential nutrients, and less dependent on chemical inputs like pesticides and fertilizers. Examples such as drought-resistant maize, pest-resistant Bt cotton, and biofortified Golden Rice highlight the potential of genetically modified organisms (GMOs) to address global issues like hunger and nutrient deficiencies. Additionally, genetic engineering can promote sustainable farming by conserving water, reducing greenhouse gas emissions, and optimizing land use. However, the adoption of this technology is not without ethical and environmental concerns, including biodiversity impacts, corporate monopolization, and public skepticism about GMOs. Addressing these challenges through transparent research, robust regulatory oversight, and equitable access to innovations is critical. By responsibly harnessing the potential of genetic engineering, agriculture can be transformed into a more sustainable and equitable system capable of feeding a growing global population while preserving natural resources and promoting environmental health.
- 25 January 2025
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 01-04
Open AccessGenetic engineering in agriculture: Bridging plant science and molecular biology for sustainable solutions
Genetic engineering in agriculture has emerged as a groundbreaking approach to tackling some of the most pressing challenges of the modern era, including food security, environmental sustainability, and malnutrition. By integrating plant science with molecular biology, this innovative technology enables the development of crops that are more resilient to environmental stressors, enriched with essential nutrients, and less dependent on chemical inputs like pesticides and fertilizers. Examples such as drought-resistant maize, pest-resistant Bt cotton, and biofortified Golden Rice highlight the potential of genetically modified organisms (GMOs) to address global issues like hunger and nutrient deficiencies. Additionally, genetic engineering can promote sustainable farming by conserving water, reducing greenhouse gas emissions, and optimizing land use. However, the adoption of this technology is not without ethical and environmental concerns, including biodiversity impacts, corporate monopolization, and public skepticism about GMOs. Addressing these challenges through transparent research, robust regulatory oversight, and equitable access to innovations is critical. By responsibly harnessing the potential of genetic engineering, agriculture can be transformed into a more sustainable and equitable system capable of feeding a growing global population while preserving natural resources and promoting environmental health.
- Open Access
- 7 October 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (02) , 21-26
Synergistic antimicrobial potential of garlic (Allium Sativum), black cumin (Nigella Sativa), and honey against zoonotic bacteria and fungus: An in vitro study from Ethiopia
The emergence of antibiotic resistance and the evolution of new pathogenic strains have become significant global health challenges in the 21st century, necessitating the exploration of alternative therapeutic options. Herbal remedies, such as garlic, black cumin seed, and honey, have long been used in traditional medicine, but scientific validation of their antimicrobial potential remains crucial. This study aimed to explore the antimicrobial properties of garlic (Allium sativum), black cumin seed (Nigella sativa), and honey against bacteria and fungi. Various extraction methods, including cold pressing, Soxhlet extraction, hydrodistillation, and cold maceration, were used to obtain bioactive compounds from these natural ingredients. The antimicrobial activity of the extracts was evaluated in vitro using the disc diffusion method against Staphylococcus aureus (ATCC 25923), Bacillus cereus (ATCC 14579), Escherichia coli (ATCC 25922), Salmonella typhi (ATCC 19430), and Candida albicans (ATCC 10237). The results showed inhibition zones ranging from 0 to 35 mm, with black cumin oil demonstrating the highest antibacterial activity, particularly against E. coli and S. aureus. The minimum inhibitory concentrations (MIC) ranged from 6.25% to 50%. The study concluded that garlic, black cumin seed oil, and honey possess significant antimicrobial properties, either individually or in combination, suggesting their potential as natural alternatives to combat zoonotic bacterial infections and address the growing concern of drug-resistant pathogens. Further research is encouraged to explore their applications in real-world scenarios and develop new, natural antimicrobial therapies.
- 7 October 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (02) , 21-26
Open AccessSynergistic antimicrobial potential of garlic (Allium Sativum), black cumin (Nigella Sativa), and honey against zoonotic bacteria and fungus: An in vitro study from Ethiopia
The emergence of antibiotic resistance and the evolution of new pathogenic strains have become significant global health challenges in the 21st century, necessitating the exploration of alternative therapeutic options. Herbal remedies, such as garlic, black cumin seed, and honey, have long been used in traditional medicine, but scientific validation of their antimicrobial potential remains crucial. This study aimed to explore the antimicrobial properties of garlic (Allium sativum), black cumin seed (Nigella sativa), and honey against bacteria and fungi. Various extraction methods, including cold pressing, Soxhlet extraction, hydrodistillation, and cold maceration, were used to obtain bioactive compounds from these natural ingredients. The antimicrobial activity of the extracts was evaluated in vitro using the disc diffusion method against Staphylococcus aureus (ATCC 25923), Bacillus cereus (ATCC 14579), Escherichia coli (ATCC 25922), Salmonella typhi (ATCC 19430), and Candida albicans (ATCC 10237). The results showed inhibition zones ranging from 0 to 35 mm, with black cumin oil demonstrating the highest antibacterial activity, particularly against E. coli and S. aureus. The minimum inhibitory concentrations (MIC) ranged from 6.25% to 50%. The study concluded that garlic, black cumin seed oil, and honey possess significant antimicrobial properties, either individually or in combination, suggesting their potential as natural alternatives to combat zoonotic bacterial infections and address the growing concern of drug-resistant pathogens. Further research is encouraged to explore their applications in real-world scenarios and develop new, natural antimicrobial therapies.
- Open Access
- 30 August 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 26-34
Molecular detection and antibiogram profiles of Escherichia coli and Vibrio cholerae isolated from raw vegetables in the northern district of Bangladesh
Raw vegetables are essential for a well-balanced diet as they provide vitamins, minerals, dietary fiber, and phytochemicals. This study aimed to isolate, identify, and evaluate the microbial loads of Escherichia coli and Vibrio cholerae in raw vegetables sold at local markets in the Dinajpur district of Bangladesh. A total of 35 vegetable samples were collected from four markets in Dinajpur district. The isolates were identified using cultural, staining, biochemical, and molecular tests. Microbial loads were enumerated (TVC) using the pour plate technique. Molecular detection of bacterial species was confirmed targeting the 16S rRNA and groEL genes of E. coli and V. cholerae, respectively. The amplification was done on 704 bp fragments of the 16S rRNA gene of E. coli and 1117 bp fragments of Vibrio spp. For the confirmation of V. cholerae, amplification of a 418 bp fragment of the groEL gene was performed through multiplex PCR. An antimicrobial susceptibility test was conducted on all isolates of bacteria against eleven and eight antibiotics by disc diffusion. The total viable count (TVC) in potato, carrot, cabbage, cauliflower, tomato, green chili, cucumber, mustard sak, and coriander leaves were 2.4 ± 0.37, 2.2±0.14, 2.1±0.26, 1.8±0.14, 1.7±0.27, 1.5±0.33, 1.5±0.33, and 1.4±0.25 mean log colony forming units ± standard deviation/mg, respectively. Out of 35 raw vegetable samples, 16 (45.71%) and 13 (37.14%) isolates were culture positive for E. coli and V. cholerae. Subsequently, 5 (31.25%) and 4 (30.76%) isolates of E. coli and V. choleraewere confirmed positive molecularly. All 16 and 13 isolates of E. coli and V. cholerae were subjected to antibiogram testing against 11 and 8 antibiotics. E. coli isolates were highly resistant to ceftazidime, cefixime, ampicillin, and oxytetracycline, but sensitive to gentamycin, ceftriaxone, colistin, and enrofloxacin. Similarly, V. cholerae isolates were highly resistant to nalidixic acid, trimethoprim, and polymyxin, but highly sensitive to kanamycin, gentamicin, and streptomycin. The study’s findings indicate that raw vegetables pose a significant public health risk due to MDR E. coli and V. cholerae. To achieve safer levels of these bacteria in raw vegetables, good production practices and hygiene awareness are essential.
- 30 August 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 26-34
Open AccessMolecular detection and antibiogram profiles of Escherichia coli and Vibrio cholerae isolated from raw vegetables in the northern district of Bangladesh
Raw vegetables are essential for a well-balanced diet as they provide vitamins, minerals, dietary fiber, and phytochemicals. This study aimed to isolate, identify, and evaluate the microbial loads of Escherichia coli and Vibrio cholerae in raw vegetables sold at local markets in the Dinajpur district of Bangladesh. A total of 35 vegetable samples were collected from four markets in Dinajpur district. The isolates were identified using cultural, staining, biochemical, and molecular tests. Microbial loads were enumerated (TVC) using the pour plate technique. Molecular detection of bacterial species was confirmed targeting the 16S rRNA and groEL genes of E. coli and V. cholerae, respectively. The amplification was done on 704 bp fragments of the 16S rRNA gene of E. coli and 1117 bp fragments of Vibrio spp. For the confirmation of V. cholerae, amplification of a 418 bp fragment of the groEL gene was performed through multiplex PCR. An antimicrobial susceptibility test was conducted on all isolates of bacteria against eleven and eight antibiotics by disc diffusion. The total viable count (TVC) in potato, carrot, cabbage, cauliflower, tomato, green chili, cucumber, mustard sak, and coriander leaves were 2.4 ± 0.37, 2.2±0.14, 2.1±0.26, 1.8±0.14, 1.7±0.27, 1.5±0.33, 1.5±0.33, and 1.4±0.25 mean log colony forming units ± standard deviation/mg, respectively. Out of 35 raw vegetable samples, 16 (45.71%) and 13 (37.14%) isolates were culture positive for E. coli and V. cholerae. Subsequently, 5 (31.25%) and 4 (30.76%) isolates of E. coli and V. choleraewere confirmed positive molecularly. All 16 and 13 isolates of E. coli and V. cholerae were subjected to antibiogram testing against 11 and 8 antibiotics. E. coli isolates were highly resistant to ceftazidime, cefixime, ampicillin, and oxytetracycline, but sensitive to gentamycin, ceftriaxone, colistin, and enrofloxacin. Similarly, V. cholerae isolates were highly resistant to nalidixic acid, trimethoprim, and polymyxin, but highly sensitive to kanamycin, gentamicin, and streptomycin. The study’s findings indicate that raw vegetables pose a significant public health risk due to MDR E. coli and V. cholerae. To achieve safer levels of these bacteria in raw vegetables, good production practices and hygiene awareness are essential.
- Open Access
- 16 August 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 16-20
Diseases and diseases conditions of treated animals at Upazila Veterinary Hospital, Kaliganj, Jhenaidah, Bangladesh
The Upazila Veterinary Hospital (UVH) in Kaliganj Upazila, Jhenaidah, Bangladesh, plays a critical role in providing animal healthcare in a region renowned for dairy farming and rearing Black Bengal goats. Despite the sector’s importance, livestock farming in Bangladesh faces challenges such as high disease prevalence and inadequate veterinary services. This study aimed to determine the prevalence and distribution of common diseases among various species treated at UVH Kaliganj from February 2019 to April 2019. Data were collected from UVH’s daily record books, encompassing 511 animals categorized into cattle (40.70%), goats (51.85%), poultry (3.32%), and other animals (4.10%). Clinical evaluations identified 11 disease categories, and monthly variations in disease prevalence were analyzed across different age groups of animals. In cattle, the predominant diseases included worms (33.65%), foot-and-mouth disease (FMD) (8.65%), respiratory diseases (14.90%), and fever (11.05%). Goats exhibited high occurrences of worm infestations (27.92%), Peste des Petits Ruminants (PPR) (9.43%), fever (25.66%), and diarrhea (12.83%). Poultry primarily suffered from respiratory diseases (29.41%), parasitic infections (17.64%), and digestive disorders (23.52%). Other animals, including sheep and monkeys, showed diverse disease profiles, including parasitic infections (19.04%), respiratory disorders (19.04%), and fever (14.28%). Monthly analysis revealed varying disease prevalence, with peaks in February and March 2019 for both cattle and goats. Diseases were prevalent across all age groups of animals, highlighting the widespread impact on livestock health in Kaliganj Upazila. This study underscores the critical role of UVH Kaliganj in managing animal health in an agricultural community heavily reliant on dairy and goat farming. The findings suggest the need for targeted veterinary interventions to mitigate disease burdens and improve animal welfare in the region.
- 16 August 2024
- Published by Genesis Publishing Consortium Limited
- Vol. 01 (01) , 16-20
Open AccessDiseases and diseases conditions of treated animals at Upazila Veterinary Hospital, Kaliganj, Jhenaidah, Bangladesh
The Upazila Veterinary Hospital (UVH) in Kaliganj Upazila, Jhenaidah, Bangladesh, plays a critical role in providing animal healthcare in a region renowned for dairy farming and rearing Black Bengal goats. Despite the sector’s importance, livestock farming in Bangladesh faces challenges such as high disease prevalence and inadequate veterinary services. This study aimed to determine the prevalence and distribution of common diseases among various species treated at UVH Kaliganj from February 2019 to April 2019. Data were collected from UVH’s daily record books, encompassing 511 animals categorized into cattle (40.70%), goats (51.85%), poultry (3.32%), and other animals (4.10%). Clinical evaluations identified 11 disease categories, and monthly variations in disease prevalence were analyzed across different age groups of animals. In cattle, the predominant diseases included worms (33.65%), foot-and-mouth disease (FMD) (8.65%), respiratory diseases (14.90%), and fever (11.05%). Goats exhibited high occurrences of worm infestations (27.92%), Peste des Petits Ruminants (PPR) (9.43%), fever (25.66%), and diarrhea (12.83%). Poultry primarily suffered from respiratory diseases (29.41%), parasitic infections (17.64%), and digestive disorders (23.52%). Other animals, including sheep and monkeys, showed diverse disease profiles, including parasitic infections (19.04%), respiratory disorders (19.04%), and fever (14.28%). Monthly analysis revealed varying disease prevalence, with peaks in February and March 2019 for both cattle and goats. Diseases were prevalent across all age groups of animals, highlighting the widespread impact on livestock health in Kaliganj Upazila. This study underscores the critical role of UVH Kaliganj in managing animal health in an agricultural community heavily reliant on dairy and goat farming. The findings suggest the need for targeted veterinary interventions to mitigate disease burdens and improve animal welfare in the region.